Activation of p34cdc2 kinase by cyclin A by unknown
Activation of p34  cd 2  Kinase by Cyclin A 
Linda M. Roy,* Katherine I. Swenson,¢ Duncan H. Walker,* Brian !3. Gabrielli,* 
Run Sheng Li,* Helen Piwnica-Worms,§ and James L. Mailer* 
*  Howard Hughes Medical Institute and Department of Pharmacology, University of Colorado School of Medicine, Denver, 
Colorado 80262; ~  Department of Anatomy and Cellular Biology, Harvard Medical School, Boston, Massachusetts 02115; 
and §  Department of Physiology, Tufts University, Boston, Massachusetts 02111 
Abstract.  Functional clam cyclin A  and B proteins 
have been produced using a baculovirus expression 
system. Both cyclin A  and B can induce meiosis I and 
meiosis II in Xenopus in the absence of protein syn- 
thesis.  Half-maximal induction occurs at 50 nM for 
cyclin A  and 250 nM for cyclin B. Addition of 25 nM 
cyclin A  to activated Xenopus egg extracts arrested in 
the cell cycle by treatment with RNase or emetine ac- 
tivates cdc2 kinase to the normal metaphase level and 
stimulates one oscillatory cell cycle. High levels of cy- 
clin A  cause marked hyperactivation of cdc2 kinase 
and a  stable arrest at the metaphase point in the cell 
cycle. Kinetic studies demonstrate the concentration of 
cyclin A  added does not affect the  10 min lag period 
required for kinase activation or the timing of maxi- 
mal activity, but does control the rate of deactivation 
of cdc2 kinase during  exit from mitosis.  In addition, 
exogenous clam cyclin A  inhibits the degradation of 
both A- and B-type endogenous Xenopus cyclins. 
These results define a  system for investigating the bio- 
chemistry and regulation of cdc2 kinase activation by 
cyclin A. 
ECEN  r LV, there has been significant progress in under- 
standing  control of the  cell cycle restriction  point 
governing transit  from G2 phase into M phase (Pines 
and Hunter,  1990, for review).  Genetically,  studies  in the 
fission yeast Schizosaccharomyces pombe demonstrated that 
the  cdc2  ÷ gene,  which encodes a  34-kD  serine/threonine 
protein kinase,  was a major locus of control over the G2 
M transition  (Nurse and Bisset,  1981; Simanis  and Nurse, 
1986; Nurse et al.,  1976). The human homologue of cdc2  ÷ 
was cloned by complementation in S. pombe, providing evi- 
dence of functional  conservation  of cell cycle control ele- 
ments over a billion years of evolution (Lee and Nurse,  1987). 
Biochemically,  the product of the cdc2  ÷ gene,  designated 
p34  cat2, was found to be the protein kinase subunit of puri- 
fied  maturation-promoting  factor  (MPF)  ~ (Gautier  et al., 
1988; Dunphy et al., 1988). MPF had been identified many 
years ago as an activity able to cause entry into mitosis or 
meiosis in vivo or in vitro in a variety of systems, suggesting 
it was a fundamental  regulatory element (Masui and Mar- 
kert, 1971; Kishimoto et al.,  1982). As purified,  MPF con- 
tains p34  '~c2 complexed with a B-type cyclin (Gautier et al., 
1990; Labb6 et al., 1989). Cyclins were first identified in fer- 
tilized marine invertebrate eggs as proteins that accumulated 
during interphase but were then quantitatively  degraded near 
the metaphase/anaphase  transition  (Evans et al., 1983; Stan- 
dart et al., 1987). Subsequent studies have shown that cyclins 
fall into two classes,  designated A and B, that can be distin- 
1. Abbreviations  used in this paper: CSE cytostatic factor; MPE M-phase 
promoting factor;  PMSG, pregnant mare's serum gonadotropin. 
guished  by sequence similarity  as well as by their kinetics 
of degradation  in the cell cycle (Westendorf et al.,  1989; 
Minshull  et al.,  1989, 1990).  B-type cyclins are related  in 
sequence to the cdcl3  + gene in S. pombe, whose product is 
known to form a complex with p34  ~2 and to be degraded 
at metaphase  (Booher and Beach,  1988;  Solomon et al., 
1988; Goebl and Byers,  1988; Hagan et al.,  1988). 
Many aspects of cell cycle control appear to be explained 
by changes in the abundance or activity of the cyclin compo- 
nent, which in turn is thought to affect the protein kinase ac- 
tivity of p34  cdc2 by mechanisms  that include stimulation  of 
the phosphorylation and dephosphorylation of the kinase it- 
self on both tyrosine and threonine residues (Solomon et al., 
1991). Interest  in the action of cyclin came originally  from 
the finding that injection of synthetic mRNA for clam cyclin 
A or B into Xenopus oocytes stimulated  the G2 ~  M transi- 
tion  (Swenson et al.,  1986; Westendorf et al.,  1989).  Be- 
cause of the regulated nature of cyclin abundance in fertilized 
marine eggs, it seemed likely from these results that the syn- 
thesis  of cyclin  represented  the  well-documented protein 
synthesis requirement  for meiosis I and II in Xenopus (Was- 
serman and Masui,  1975; Gerhart et al.,  1984).  However, 
subsequent studies by Sagata, Vande Woude, and co-workers 
and others have demonstrated that increased synthesis of the 
mos  ~e protooncogene,  which encodes a serine/threonine  pro- 
tein kinase,  is both necessary and sufficient for meiotic cell 
cycles in Xenopus (Sagata  et al.,  1988, 1989a;  Freeman et 
al.,  1989; Barrett et al.,  1990).  Consistent with a require- 
ment for the synthesis of rnos  ~e during  the meiotic cycles of 
oocyte maturation  and the amplification  of MPF  activity 
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1975), recent work demonstrates that cyclin B2 preexists in 
resting (32 phase oocytes and is already partially phosphory- 
lated  and associated with p34  ~c2  in  an  inactive complex 
called pre-MPF (Gautier and Mailer,  1991). In extracts of 
activated eggs, B-type cyclins, and mog" kinase are thought 
to be degraded at exit from M phase (Murray and Kirschner, 
1989;  Watanabe et al.,  1989),  and activation of p34  ~cz ki- 
nase in the first mitotic cell cycle is dependent on the synthe- 
sis of  cyclin B (Minshull et al., 1989; Murray and Kirschner, 
1989). Expression in extracts of nondegradable forms of cy- 
clin B leads to a stable arrest in metaphase, and a high level 
of H1 protein kinase activity of p34 ~2 (Murray et al., 1989). 
In nearly all this previous work, the focus has been on cy- 
clin B rather than cyclin A, and functional cyclin B has been 
produced by translation of synthetic mRNA in cells or in ex- 
tracts. A  number of important questions about the role of 
cyclin A  merit urgent attention.  These questions include 
whether cyclin A mRN'A or protein can drive mitotic cell cy- 
cles in the absence of cyclin B or other new proteins. Is the 
mechanism whereby  cyclin A  activates p34  ~d~2 kinase the 
same as cyclin B? We believe these questions are difficult to 
answer when expressing cyclin by translation of synthetic 
mRNA because the concentration of cyclin is continuously 
changing throughout the experiment.  To begin to address 
these  questions biochemically, we  have used insect cells 
(Sf9) infected with recombinant baculovirus encoding clam 
cyclin A and B genes to produce functional cyclin proteins, 
permitting us to carry out experiments with defined concen- 
trations of cyclin without the need for protein synthesis. In 
this paper we have compared these cyclins for their ability 
to stimulate meiotic cell cycles and probed the mechanism 
of activation of p34 ~d~2 kinase by cyclin A in mitotic cycles. 
Materials and Methods 
Preparation of Murray and Cytostatic Factor 
(CSF) Extracts 
Female Xenopus laevis (Xenopus I, Ann Arbor, MI) were primed with 50 
and 25 U of PMSG (pregnant mare's serum gonadotropin) 5 and 3 d, respec- 
tively, before the experiment. The frogs were then injected with 100 U HCG 
(human chorionic gonadotropin) 14-16 h before the experiment. The eggs 
were laid in lx Mailer Modified Ringer's (MMR) (110 mM NaCI, 1.8 rnM 
KCI,  1 mM MgCI2,  2 mM CaCl2, 5 mM Na Hepes, pH 7.8).  Oscillating 
extracts were prepared as described by Murray and Kirschner (1989)  with 
several modifications. Instead of electrical activation, the eggs were acti- 
vated by a 60-80-s treatment in 0.2x  MMR with the calcium ionophore 
A23187 at 5 #g/ml of eggs, followed by at least ten washes with 0.2 x  MMR. 
At the times indicated in the figures, aliquots of the oscillating extract were 
taken and diluted 20 times with distilled H20 to arrest cycling, immedi- 
ately frozen in dry ice, and later assayed for histone HI kinase activity.  In 
some experiments aliquots of extracts were visualized by fluorescence mi- 
croscopy to ascertain nuclear morphology, as described previously (Lohka 
and Mailer,  1985).  To inhibit oscillation of the cell cycle, extracts were 
treated at 10°C for 20 rain with 0.3 #g/ml DNase-free ribonuclease (Boeh- 
ringer-Mannheim Biochemicals, Indianapolis, IN). Placental ribonuclease 
inhibitor, RNAsin (Promega Biotec, Madison, WI) was then added to a final 
concentration of 1,500  U/ml, and the extracts were further incubated for 
15 rain at 10°C. Alternatively emetine was added to 100 #M to inhibit pro- 
tein synthesis. Extracts were incubated at 230C during oscillations. Assays 
at 0 time represent samples measured just before incubation at 23°C. CSF- 
arrested extracts were prepared according to the protocol for oscillating ex- 
tracts with the following modifications. Before being crushed, the eggs were 
washed twice with extract buffer (10 mM K-Hepes, pH 7.7, 100 mM KC1, 
0.1 mM CaC12, 1 mM MgCl2, 50 mM Sucrose) containing 5 mM EGTA 
and a  further  l  mM MgC12. The eggs were not activated before being 
crushed and thus the extracts remained arrested in M phase until treatment 
with 0.2  mM CaCI2  released them into interphase (Lohka and  Mailer, 
1985). 
Histone HI Kinase Activity 
Histone H1 kinase assays were carried out as previously described (Gautier 
et al., 1989). The samples were analyzed by SDS-PAGE (Laemmli, 1970), 
excision of histone H1 band, and determination of incorporated radioactiv- 
ity by Cherenkov counting. The conditions under which these assays were 
carded out have been previously shown to be specific for p34  cacz kinase as 
judged by analysis of sites phosphorylated in histone H1 as well as by the 
lack of effect of known inhibitors of other H1 kinases (Langan et al., 1989). 
In addition, oscillatory behavior reported here has also been observed with 
kinase activity adsorbed to p13 svcl Sepharose beads, a reagent with high 
affinity for p34  ~c2. 
Isolation  of Xenopus cdc2/Cyclin  Complexes on p13  svcl 
p13 svcj was purified from an overproducing Escherichia coli BL21  (DE3) 
strain after a procedure modified from Brizuela et al. (1987).  The p13 svct 
protein was coupled to activated CH-Sepharose CL-4B beads (Pharmacia 
Fine Chemicals) at 4°C for I h at pH 6.5, with a final concentration of SUCI 
on the bead of 5 mg/ml of resin. To adsorb the cdc2/cyclin  complexes from 
the Xenopus extracts, 5-~1 samples were diluted with 150 #1 of buffer con- 
taining 20 raM Hepes, pH 7.5,  15 mM MgCI2, 20 mM EGTA, 15 M DTT, 
80 mM/~GP, 0.5 mM PMSE 3 ~tg/ml leupeptin, 50 mM NaE 1 mM sodium 
vanadate, 0.2 mM ammonium molybdate, 30 mM p-nitropbenol phosphate, 
and precleared with 50 #1 of 50% Sepharose beads. After centrifugation at 
16,000 g for 5 min, the supernatant was transferred to fresh tubes and mixed 
with 25 #1 of a 50% pl3-Sepharose suspension for 1 h. The isolated com- 
plexes were prepared for the H1 kinase assay by washing the beads with a 
buffer containing 20 mM Tris pH 7.4,  5 mM EDTA,  100 mM NaC1,  1% 
TX-100, twice with the same buffer containing 1 M NaCI, and finally twice 
with the HI  kinase buffer.  The 3sS-labeled  complexes were washed three 
times with RIPA buffer (20 mM Tris pH 7.4, 5 mM EDTA, 100 mM NaC1, 
0.1%  SDS, 0.5%  deoxycholate, 1%  NP-40), twice with RIPA containing 
1 M  NaCI, and twice more with RIPA buffer.  The p13 svc t precipitates 
were analyzed by electrophoresis on 10% Anderson gels (Anderson et al., 
1973)  and fluorography. 
Cell Lines and Generation of 
Recombinant Baculovirus 
Spodopterafrugiperda  (Sf9) cells were obtained from the American Type 
Tissue  Culture  Collection (Rockville,  MD).  Sf9  cells were cultured  in 
Grace's Antheraea medium supplemented with  10%  FBS,  3.3  g/liter of 
yeastolate, 3.3 g/liter of lactalbumin hydrolysate, and 50 ~g/mi gentamicin 
at 27°C. All procedures relating to viral propagation, isolation, and plaque- 
ing were performed as suggested by Summers and Smith (1987).  pCDI02 
containing the gene encoding clam cyclin B (Westendorf  et al., 1989) was 
linearized with HindlII and a BgllI linker was inserted. The resulting plas- 
mid was then linearized with Xbal and a BgllI linker was inserted to gener- 
ate pCD102(BgllI), pCDI02(BglII) was then digested with BgllI and the 1.7- 
kb insert containing the cyclin B gene was cloned into the BamHI site of 
pVL941 (Luckow and Summers, 1988) to generate pVL941(B),  pAXH(+) 
containing the gene encoding clam cyclin A (Swenson et al., 1986) was lin- 
earized with HindlII and a BamHI linker inserted. The resulting plasmid 
was digested with BamHI and the 1.5-kb fragment containing the cyclin A 
gene was cloned into the BamHI site of pVL941  to generate pVL941(A). 
Sf9 ceils were transfected with a mixture of 1 /~g of purified wild-type 
viral DNA and 2 tzg of either pVL941(A) or pVL941(B).  5 d after transfec- 
tion,  medium  supernatants  containing both  wild-type and  recombinant 
viruses were collected and plaqued onto a monolayer of Sf9 cells. Recom- 
binant viruses were identified by their occlusion negative phenotype and 
were  isolated by  plaque  purification as  described previously  (Piwnica- 
Worms et al.,  1990).  Recombinant proteins were detected by immunoblot 
analysis (Fig.  1). 
To generate active cyclin lysates, baculovirus-infected cells were soni- 
cared five times (5-s bursts) using a Kontes microultrasonic cell disrupter 
(Vineland, NJ)  in a buffer containing 20 mM Tris-HCl (pH 7.5)  50 mM 
NaC1, and 1 mM DTT. In some experiments extracts were clarified by cen- 
trifugation  at  15,000  g  for  10  min.  In  dose-response experiments the 
baculovirus-produced cyclin was diluted with the same buffer and added to 
a final volume of 50/~1 of the oscillating extract. Control additions used ly- 
The loumal of Cell Biology,  Volume 113, 1991  508 sates of Sf9 cells with wild-type baculovirus. Similar results were obtained 
in at least three independent experiments with multiple preparations of cy- 
clins. Cyclin activity was stable to freeze-thawing, and experiments com- 
paring potencies of cyclins A and B in oocytes utilized aiiquots of the same 
lysates. Quantitation of cyclin A  and B content in Sf9 cell lysates was as- 
sessed by densitometrie scanning of Coomassie blue-stained gels contain- 
ing either cyelin lysates at various dilutions or known amounts of glutamate 
dehydrogenase (Mr  =  48 kD). A  standard curve of glutamate dehydroge- 
nase densitometric units was then constructed to assess the concentration 
of  cyclin A or B in samples diluted to fit in the linear portion of  the standard 
curve. The stock concentration of cyclin A and B in the lysates used in this 
paper was 4/zM, constituting '~10% of  the total protein. This is '~200 times 
greater than the effective concentration in extracts, and inasmuch as cyclin 
was  a  major Coomassie blue  staining band,  equivalent to  a  2,000-fold 
purification from eggs, no further purification of cyclin beyond the level 
achieved by overexpression was carried out. Intracellular concentrations of 
cyclins after microinjection of 50-nl volumes into oocytes were calculated 
on the basis of 0.5/zl of cell water per oocyte (Stith and Mailer,  1985).  In 
all injection experiments stage VI oocytes from frogs primed 3 d earlier with 
35  IU PMSG were manually  dissected out of their follicular envelopes 
on the ovary and cultured in modified medium OR-2 containing 10 mM 
NaHCO3, pH 7.8. 
Anti-cyclin Antibodies and Immunoblot Analysis 
Affinity-purified anti-cyclin A and anti-cyclin B antibodies were produced 
and characterized as described by Swenson et al. (1986) and Westendorf et 
al. (1989) respectively. Lysates of insect cells infected with wild-type or cy- 
clin recombinant baculoviruses were dissolved in SDS sample buffer and 
separated by SDS-PAGE and blotted onto nitrocellulose paper in parallel 
with samples made from mitotic clam embryos prepared 75 min after fertil- 
ization, as described by Swenson et al.  (1986).  Gel blots were incubated 
with affinity-purified antibodies, then with an alkaline-phosphatase con- 
jugated secondary antibody (Promega Biotec), and developed according to 
the manufacturer's instructions. 
Results 
Cyclins Stimulate Meiosis I and H in the Absence of 
Protein Synthesis 
Since all previous reports on the ability of cyclins to stimu- 
late oocyte maturation have used injection of synthetic mRNA 
for clam cyclin A or B (Swenson et al.,  1986; Westendorf 
et al., 1989), it is unclear whether synthesis of other proteins 
is required for cyclin-induced oocyte maturation and more 
specifically, whether the mos  ~e kinase is  required.  To ad- 
dress this question, we overproduced active clam cyclin A 
and B proteins in Sf9 (Spodoptera frugiperda) cells using a 
baculovirus expression system. Fig.  1 1 shows total lysate 
proteins prepared from cells infected with wild-type virus or 
recombinant virus encoding either cyclin A or cyclin B. Im- 
munoblot analysis using anti-cyclin A or B antibodies dem- 
onstrated that the prominent overproduced Coomassie blue 
staining bands were in fact cyclin and that they co-migrated 
with the cyclin produced in intact clam eggs (Fig.  1, H and 
III).  Analysis of lysates from cells infected with wild-type 
baculovirus showed neither a prominent Coomassie staining 
band at the relative molecular mass of cyclin A or B nor any 
immunoreactive band (Fig.  1). In insect cells, both cyclins 
associate with coexpressed cdc2 and activate p34  cdc2 kinase 
activity to equivalent extents; both complexes are also phos- 
phorylated on tyrosine 15 of cdc2 kinase when co-expressed 
with the wee I ÷ gene (Parker et al.,  1991).  To determine 
whether baculovirus-produced cyclins were functionally ac- 
tive in  regulating Xenopus  meiotic cell cycles, we micro- 
injected cyclin A  lysates  into  oocytes in  the presence or 
absence of cycloheximide and monitored germinal vesicle 
breakdown (GVBD) as a measure of entry into meiosis I. As 
shown in Fig. 2 A, cyclin A was able to induce GVBD very 
rapidly (1-2 h), causing 100% GVBD in the presence or ab- 
sence of cycloheximide. Control injections with lysates of 
Sf9 cells infected with wild-type virus had no detectable ac- 
tivity. Cycloheximide treatment has previously been shown 
to reduce mos  x` below levels functional for GVBD (Sagata 
et al.,  1989a). Therefore these results indicate cyclin A-in- 
duced maturation meets the criteria for MPF-induced matu- 
ration and  does not require the c-mos ~e protein kinase or 
any other newly synthesized protein. 
An important question concerns whether cyclins A and B 
have identical properties in cell cycle control. Therefore, as 
shown in Fig. 2 B, lysates containing various concentrations 
of cyclin A and B were microinjected into cycloheximide- 
treated oocytes, and the frequency of GVBD was assessed 
2 h later. Both cyclins were able to induce GVBD, but cyclin 
B  was  only about  one-fifth as  potent as  cyclin A.  Half- 
maximal stimulation occurred at 50 nM for cyclin A and 250 
nM for cyclin B. Lysates of cells infected with wild-type vi- 
rus had no effect even when injected at much higher concen- 
trations. Previous work by Gerhart et al.  (1984)  has shown 
that protein synthesis is also required for the transition be- 
tween meiosis I and meiosis II in Xenopus.  During normal 
Figure 1. Characterization of clam cyclin A 
and B expressed in a recombinant baculovi- 
rus system. (I) Coomassie blue-stained pro- 
teins evident in aliquots of Sf9 cell lysates 
infected with wild-type virus (lane 1 ), re- 
combinant cyclin A virus (lane 2), and re- 
combinant cyclin B virus (lane 3). The ar- 
rows in lanes 2 and 3 mark the prominent 
cyclin bands. (II) Samples as in 1, lanes 1 
and 2, were subjected to Western blotting 
with anti-cyclin A antibody. Lane 1, wild- 
type; lane 2, fertilized clam egg lysate; lane 
3, lysate from Sf9 cells infected with virus 
encoding cyclin A. (III) The same experi- 
ment as in H was carried out except anti- 
cyclin B antibody was used and lane 3 con- 
tained lysates  of Sf9 cells infected with virus 
encoding cyclin B. 
Roy et al.  Cell Cycle Control by Cyclin A  509 60 
o 
o  40  80  120  1150  200  0 
Time  (min) 
16  16 
X  X 
0  ~  ~t--- -A--  -- --A  j  0 
0 
0  2  4  6  8  10 
Time  (h) 
300  600  900  1200 1500 
Cyclin.  nM 
2  4  6  8  10 
Time  (h) 
Figure 2. Induction of meiosis by cyclins A and B. (A) Clam cyclin 
A induces GVBD. Oocytes were injected with cyclin A lysates and 
the  rate  of germinal  vesicle  breakdown  (GVBD)  was  assessed. 
When present,  cycloheximide was used at 10 #g/ml for 30 min be- 
fore injection as well as during and after microinjection.  The final 
intracellular  concentration of cyclin A was 250 nM. Control injec- 
tions  of lysates  from cells  infected  with wild-type virus had no 
effect.  D----D, with  cycloheximide;  H,  without cycloheximide. 
(B) Quantitative  comparison of cyclin A and B for GVBD. Oocytes 
were incubated  in medium OR-2 containing 10 #g/ml cyclohexi- 
mide for 30 min before injection as well as during and after injec- 
tion. Oocytes were injected to the indicated  final intracellular  con- 
centration  of either  cyclin A  or B  in  Sf9  cell  lysates  and  the 
frequency of GVBD assessed after 2 h. Half-maximal  induction oc- 
curred at 50 nM for cyclin  A  (t3---D) and 250 nM  for cyclin  B 
(H).  No GVBD occurred with lysates of wild-type infected cells 
at concentrations corresponding to extracts  containing 1,200 nM 
cyclin. (C) Effect of cycloheximide on p34  ~dc2 kinase in meiosis II. 
Oocytes were treated with progesterone (10 #g/ml) at zero time and 
the time course of activation  of the H1 histone kinase  activity  of 
p34  ~dc2 assessed (D----D). GVBDs0 occurred at 3.5 h. In some cases, 
oocytes which had undergone GVBD within the previous 10 min 
(denoted by the arrow) were injected with cycloheximide  in OR-2 
to give an intracellular  concentration of 5 #g/ml and the time course 
of p34  cat2 kinase  activity assessed  (k---&). Control injections  of 
OR-2 had no effect (not shown).  (D) Reactivation of meiosis II by 
clam cyclins A or B. The same experiment as in C is shown for oo- 
cytes injected with cycloheximide just after GVBD (~--i). At 5 h 
(cyclin A) or 5.25 h (cyclin B) lysates containing cyclin A (o---o) 
or cyclin B (~---~) were microinjected  to give intracellular  con- 
centrations  of 66 and  200 nM,  respectively  and the activity  of 
p34  cat2 kinase assessed  for a subsequent  3-4 h period. Control in- 
jections of lysates  from wild-type baculovirus-infected  Sf9 cells 
had no effect. 
progesterone-induced oocyte maturation,  the level of MPF 
activity  as  measured  by  the  oocyte  microinjection  assay 
declines by •50%  1-2 h after GVBD in conjunction with the 
metaphase/anaphase transition of meiosis I. This decline in 
MPF  is  transient  and  levels  soon return  to that  seen  in a 
metaphase II-arrested egg; however, if cycloheximide is in- 
jected just after GVBD, MPF declines abruptly to undetect- 
able levels and remains low (Gerhart et al.,  1984).  Fig. 2 C 
shows that the same effect of cycloheximide can also be mea- 
sured by assessing  the HI  kinase  activity of p34  ~dc2 rather 
than MPF activity for GVBD in the microinjection assay. 
Studies by Sagata and Vande Woude have shown that the 
metaphase II arrest of the egg is dependent on expression of 
mos  ~e which appears to have a very short half-life (Sagata et 
al.,  1989b). Therefore, it seems likely the protein synthesis 
requirement for Meiosis II, like Meiosis I, is also accounted 
for by synthesis of the mos  ~  kinase.  Since a possible target 
for phosphorylation by mos  ~' is cyclin B2 in pre-MPF (Roy 
et al., 1990), it seemed plausible that functional cyclin could 
rescue a meiosis II cell cycle made defective by the absence 
of c-mos  ~e.  To assess  this  possibility,  either  cyclin A  or B 
lysates were microinjected into oocytes that had been previ- 
ously injected with cycloheximide immediately after under- 
going progesterone-induced GVBD. As shown in Fig. 2 D, 
both cyclins caused an immediate increase in the H1 kinase 
activity of p34  cdc2 in the presence of cycloheximide. At the 
concentration of cyclin used, this increase reached the same 
level as  in metaphase  II-arrested oocytes, but unlike  con- 
trois, which exhibit a stable metaphase II H1 kinase activity 
(cf. Fig. 2 A), cyclin-injected oocytes underwent a rapid de- 
cline in H1 kinase activity after reaching metaphase II levels, 
presumably reflecting exit from second meiotic metaphase 
into interphase.  This might be a consequence of the absence 
of c-mos% which is necessary for metaphase II arrest (Sa- 
gata et al.,  1989b). This rescue of a cycloheximide-inhibited 
cell cycle by cyclin occurred at concentrations of cyclin simi- 
lar to those that caused GVBD and meiosis I. However, at 
higher concentrations  of cyclin A,  H1  kinase  activity was 
elevated to levels higher than progesterone controls at GVBD, 
and H1 kinase activity remained high for a prolonged period 
(data not shown). 
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Figure 3. Cyclin A drives mitotic cell cycles. (A) Effects of RNase 
on oscillation  of p34  ~dc2 kinase.  Oscillating  extracts were prepared 
as described in Materials  and Methods with  (Ey---~) or without 
(e  =) treatment  with  RNase.  The RNased extract  was  supple- 
mented with a wild-type Sf9 cell lysate.  (B) Effect of cyclin A on 
p34  cdc2 kinase.  To the same RNased extracts depicted in A, lysates 
containing various concentrations of cyclin A were added at zero 
time and the activity  of p34  cdc2 kinase  assessed  over a 2-h period 
encompassing two oscillations  in controls (cf. A). Inset: The maxi- 
mal amplitude  of HI kinase activity at 45 min is plotted  (ordinate) 
as a function of the final concentration of cyclin A in the extract 
(abscissa). Units on the axes in the inset are the same. D--O, wild- 
type; ~---~, 25 nM cyclin A; o----o, 50 nM cyclin A; H,  100 
nM cyclin A; (=  =), 250 nM cyclin A. 
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Cyclin 
Minutes  Control  RNase  A-treated 
0  +  +  + 
10  +  +  + 
20  +  ?  + 
30  +  +  + 
40  +  +  + 
50  +  +  + 
60  -  -  + 
70  -  -  + 
80  +  -  + 
90  +  -  + 
100  +  -  + 
110  -  -  + 
120  -  -  + 
130  +  -  + 
The  effect of oscillating  extracts  on  nuclear  morphology  was determined  by 
adding  sperm  pronuclei  (100,000/ml)  to  the  different  extracts  at  time  zero. 
Samples  were taken  at different  times,  stained  withDAPI,  and  examined by 
phase and fluorescence microscopy to identify the phases of the nuclei.  Cyclin 
A-treated  extracts  contained  250  nM cyclin  A.  +,  mitotic  chromosomes;  -, 
interphase  nuclei. 
(Fig. 3 A). However, increasing amounts of cyclin A caused 
cycles with the same initial lag but with elevated maxima of 
p34  cd~2 kinase activity.  The kinase activity maxima occurred 
at 45  min  regardless  of the amount of cyclin added,  but 
initial rates of activation were higher as cyclin concentration 
increased.  At  high  concentrations  of cyclin  (>1250 nM), 
p34  ~dc2 kinase activity became hyperactivated about eight- 
fold at the metaphase (45 min) point in the cycle, and it main- 
tained high activity for several hours, behaving essentially 
like a  CSF-arrested extract.  Examination of nuclear mor- 
phology in such extracts confirmed that HI kinase activity 
was a consistent measure of cell cycle stage (Table I). The 
inset in Fig.  3 B  shows  a linear relation between a  10-fold 
range of cyclin A  protein added and the maximal level of 
p34  ~2 kinase activation, suggesting a direct interaction be- 
tween cyclin A and cdc2 kinase. Consistent with the expected 
association of MPF subunits, experiments with [35S]methio- 
nine-labeled cyclin A from Sf9 cells showed that added cy- 
clin could rapidly be recovered bound to cdc2 kinase on 
p13  sUc~-Sepharose beads (data not shown). 
Also evident from these experiments was the decline in the 
Cyclin A Activation of  p34~Z  for Mitotic Cell Cycles 
Murray and Kirschner (1989) modified the original Xenopus 
egg extraction protocol of Lohka to produce mitotic extracts 
that would oscillate spontaneously between DNA replication 
and mitosis. These oscillatory egg extracts have been called 
by many investigators Murray extracts to distinguish them 
from Lohka extracts, which require addition of exogenous 
components  to  transit  cell  cycle  restriction points.  They 
demonstrated that in extracts made shortly after egg activa- 
tion sea urchin cyclin B mRNA alone could drive a Xenopus 
cell cycle from interphase into M-phase, and cyclin B degra- 
dation was required to exit M phase (Murray and Kirschner, 
1989;  Murray  et  al.,  1989).  Within  a  certain  range,  the 
length of  the cell cycle  before the activation of  MPF appeared 
to be dependent on the concentration of newly translated cy- 
clin B added in a reticulocyte lysate, suggesting the amount 
of cyclin B present controlled the rate of p34  uc2 kinase acti- 
vation  and  cell  cycle progression  (Murray  et  al.,  1989). 
However, only a twofold range of active cyclin mRNA was 
tested  for effectiveness in  driving  the  cycle (Murray  and 
Kirschner,  1989). 
None of the previous work in  mitotic extracts  has  ad- 
dressed the function of cyclin A. To address whether cyclin 
A translation was sufficient for entry into mitotic cell cycles, 
we developed a sensitive and quantitative assay for cyclin A 
activation of cdc2 kinase utilizing addition of defined con- 
centrations of  baculovirus-produced clam cyclin A protein to 
RNase-treated Murray extracts. As shown in Fig. 3 A, con- 
trol extracts carried out two consecutive cycles with a peri- 
odicity of 40-50 rain that were absent in RNase-treated ex- 
tracts to which lysates from wild-type-infected cells were 
added. These oscillations exhibited identical kinetics whether 
assayed in  extracts  or after immobilization on Sepharose 
beads covalently linked to p13  sUc~. Fig. 3 B shows the effect 
of adding increasing amounts of cyclin A to an RNased ex- 
tract. After a lag of 10 rain, as little as 25 nM cyclin was able 
to  restore one cycle of activation of p34  ~c2 kinase to ap- 
proximately the same level as at metaphase in a control cycle 
Figure 4. Clam cyclin A blocks degradation of Xenopus cyclins A, 
B1, and B2. Oscillating extracts were prepared and supplemented 
with [35S]Trans-label  (ICN Radiochemicals, Irvine, CA) (1 #Ci/#l 
extract before shifting to 23°C).  Labeled cyclin/cdc2 complexes 
were isolated using pl3SUc1-Sepharose  beads and analyzed by SDS- 
gel electrophoresis as described in Materials and Methods. Parallel 
samples were taken to determine the histone H1 activity of the iso- 
lated complexes. (Top) Untreated oscillating extracts (control). (Bot- 
tom) Oscillating extracts treated with lysate containing clam cyclin 
A (final concentration 250 nM). 
Roy  et al.  Cell Cycle  Control  by Cyclin A  511 ~r 
O 
-7 
21- 
z7 
o; 
Time  ~nird 
B 
i 
o4 
o  ~  ~o 
Time  C,'nin~ 
-7 
18o 
15" 
IO- 
°  d,  ,~ 
Time  ~in) 
Figure 5.  Activation of cdc2 
kinase by cyclin A after exit 
from M phase. (A) Oscillating 
extracts  were  prepared  and 
incubated  as  described  in 
Materials and Methods. At 60 
min after initiating the  cycle 
(when the first M phase was 
completed), emetine was added 
to a final concentration of 100 
#M (thick arrow), and the ex- 
tract was allowed to incubate 
further at 23°C.  35 min after 
emetine addition,  the sample 
was divided into two aliquots, 
with one receiving clam cyclin 
A  (thin arrow) (closed trian- 
gles,  final  concentration  of 
cyclin A, 25 nM). Emetine alone, open triangles. (B) CSF extracts were prepared as described in Materials and Methods. 0.2 mM CaCI2 
was added at 0 min and 80 min to all extracts. The control extract (c>--~) was performed in the absence of emetine, and is the same extract 
in both B and C. 100/zM emetine was added to the extracts at 0 min, then supplemented with either 250 nM cyclin A or wild-type Sf9 
cell lysate (H)  at 25 rain (thin arrow), and the activity of cdc2 kinase monitored by H1 kinase activity. (C) CSF extract was treated 
with calcium at 0 min and allowed to progress until arrest at first mitotic metaphase was evident. 100/~M emetine was added to the extracts 
along with 0.2 mM CaC12 (80 min, thick arrow), which caused release from mitotic metaphase  arrest.  The extracts were then supple- 
mented with either 250 nM cyclin A (~---~) or wild-type infected Sf9 cell lysate (H)  at 105 min (thin arrow) and the activity of cdc2 
kinase monitored. 
rate of p34  cdc2 kinase  deactivation at progressively higher 
concentrations of cyclin (Fig. 3 B). To determine if this rep- 
resented effects on cyclin degradation,  studies were carried 
out with [35S]methionine  in Murray extracts to which unla- 
beled cyclin A had been added. As shown in Fig. 4, clam cy- 
clin A addition delayed the degradation of both the A- and 
B-type endogenous Xenopus cyclins in Murray extracts. This 
supports the idea that the level of cyclin A determines the rate 
of exit from M phase (like cyclin B, Murray and Kirschner, 
1989) but does not normally control the rate of entry into M 
phase. 
These results suggested that cyclin A in the absence of pro- 
tein synthesis was sufficient to stimulate a round of cdc2 ld- 
nase activation as well as subsequent degradation of the cy- 
clin and kinase inactivation. A similar conclusion relative to 
cyclin B has been made earlier from the work of Murray and 
Kirschner. However, in the preparation of Murray extracts, 
eggs are activated for 30 min before crushing (see Materials 
and  Methods)  raising  the possibility that the  extract con- 
tained some level of newly synthesized cyclin or some other 
protein. This level would have to be rather low since RNase 
treatment caused arrest of the cell cycle (Fig. 3) and okadaic 
acid addition to extracts made at this time does not cause pre- 
MPF activation (Felix et al:,  1990). To assess the ability of 
cyclin A to act alone more rigorously, we investigated cyclin 
A action in extracts that had already completed one cycle of 
MPF activation and inactivation in vitro. Fig. 5 A shows that 
addition of emetine after one cycle in an oscillating Murray 
extract abolishes further activation of cdc2 kinase, but cyclin 
A  addition  still  causes  activation  of cdc2  kinase  to  the 
metaphase level.  Control experiments have confirmed that 
all newly  synthesized  cyclins bound  to p13  svc~ beads  are 
degraded in these extracts at exit from M phase (Fig. 4, con- 
trol). Other experiments examined cyclin A action after re- 
lease of an extract from a CSF arrest.  Such extracts retain 
the metaphase arrest of the unfertilized egg and can be stimu- 
lated to degrade cyclin, exit meiosis II, and enter mitotic cell 
cycles by addition of calcium ion, the normal trigger occur- 
ring intracellularly at fertilization (Lohka and Mailer, 1985; 
Solomon et al., 1991).  As shown in Fig. 5 B, cyclin A addi- 
tion to emetine-treated CSF extracts that had exited from 
meiosis II was able to cause a marked and stable hyperactiva- 
tion of cdc2 kinase. CSF extracts treated with calcium nor- 
mally arrest again at first mitotic metaphase (Fig. 5 C), but 
a second addition of calcium also causes release from first 
mitotic metaphase. As shown in Fig. 5 C, cyclin A was able 
to activate cdc2 kinase after a second M phase in vitro, indi- 
cating cyclin A does not require cyclin B or any other newly 
synthesized protein to activate cdc2 kinase after exit from 
meiosis or mitosis. 
Discussion 
The results presented in this paper provide new insights into 
the role of cyclin A  in the cell cycle and the mechanism of 
activation of p34  cd~2. Although both cyclins could stimulate 
both Xenopus meiotic cell cycles in the absence of protein 
synthesis, functional cyclin A  protein was five times more 
potent than cyclin B. Previous work has shown that mRNA 
for both cyclin A  and B  can also drive meiotic cycles, al- 
though no quantitative comparison was made, and it could 
not be determined if synthesis of other proteins was required 
(Swenson et al., 1986; Westendorf et al., 1989). It is not im- 
mediately obvious why cyclin A should be more potent than 
cyclin B. One possibility, proposed by Hunt (Minshull et al., 
1990), is that cyclin A/cdc2 complexes activate cyclin B/cdc2 
complexes. This idea is made somewhat attractive by the fact 
that cyclin B/cdc2 complexes preexist in the resting oocyte 
as "pre-MPF",  whereas cyclin A  is synthesized only after 
progesterone treatment (Gautier and Mailer, 1991). Another 
possibility is that the oocyte maintains a mechanism to inac- 
tivate B-type cyclins as  indicated  by the  store of inactive 
B-type "pre-MPF". Potentially, some of the injected cyclin B 
could be diverted to the inactive "pre-MPF" pool. Since cy- 
clin A is absent in oocytes containing pre-MPF (Minshull et 
al., 1990), no inactivation mechanism for cyclin A might be 
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is conceivable cyclin B  requires modification (phosphory- 
lation,  association with other components, etc.) before it 
can act. 
Because both cyclin A and B proteins induce maturation 
after prolonged incubation in cycloheximide, it is evident 
both cyclins act downstream or independently of the mos  ~, 
proto-oncogene product,  whose  synthesis is  required  for 
meiosis in Xenopus (Sagata et at., 1988, 1989a).  We previ- 
ously demonstrated that Xenopus cyclin B2 could be phos- 
phorylated in vitro by the mos  x" kinase (Roy et at.,  1990). 
This  may indicate cyclin protein  acts  downstream of the 
mos  ~, product rather than independently. This idea is also 
supported by the absence of a stable metaphase II activation 
of p34  ~C2 by cyclin in the absence of the mos  ~" kinase (Fig. 
2 B). Theoretically, mos could be present in insect cells and 
act together with cyclin to  stimulate meiotic cycles. This 
seems  unlikely because  the  Sf9  cell  lysates  are  greatly 
diluted  due  to  the  enormous  over-expression  of cyclin, 
reducing the concentration of any noncyclin protein to trace 
levels. In addition, the mos protooncogene has not been de- 
tected below vertebrate phyla (Vande Woude, G., personal 
communication), and wild-type Sf9 cell lysates, even at high 
concentration, did not display the CSF activity of mos  ~" in 
oocytes or oscillating Murray extracts. Moreover, Western 
blotting of concentrated Sf9 cell lysates with an antibody to 
a highly conserved domain of mos (residues 37-55 of mouse 
v-mos, Maxwell and Arlinghaus, 1985) did not show any de- 
tectable mos protein (Roy, L. M., and J. L. Mailer, unpub- 
lished data). 
The experiments with cyclin A in both Murray extracts and 
CSF extracts provide the first evidence that A-type cyclins 
alone can also drive mitotic cell cycles. The potency of cyclin 
A to restore H1 kinase to normal metaphase levels (25 nM) 
is similar to that previously found with sea urchin cyclin B 
(Murray and Kirschner, 1989; Solomon et at., 1991). But cy- 
clin A was also able to hyperactive p34  c~c~ kinase, mostly 
likely by recruitment of additional monomeric cdc2 kinase 
molecules into a complex, as judged by the ability to rapidly 
recover added cyclins on p13  svc t-Sepharose beads.  At the 
highest concentration of cyclin A  added,  cdc2  kinase ap- 
peared  to  reach  a  stably  activated  state  that  caused  a 
metaphase arrest (Table I) and cyclin stabilization (Figs.  3 
B  and 5 B).  This level  of kinase activity is about 8-10× 
greater than that seen in a normal metaphase. Since newly 
added cyclin could be recovered bound to cdc2  kinase on 
p13  svc~ beads, the increase is due to an increased number of 
cyclin/cdc2 complexes. This suggests  ~90% of the cdc2 in 
a control M phase extract is not normally activated. This idea 
is consistent with the recent work of Solomon et at. (1991) 
using cyclin B addition to egg extracts. In addition, gel filtra- 
tion of Xenopus egg extracts coupled with Western blotting 
of cdc2 shows 80-90 % of the protein migrates with a mono- 
mer molecular weight, but all kinase activity is associated 
with a minor fraction eluting with other components at Mr 
=  170,000  (Gabrielli, B., and J. Mailer, in preparation). 
That cyclin A could prevent degradation of both Xenopus 
B-type cyclins suggests that the same protease acts on both 
types of cyclin, or alternatively, the same type of modifica- 
tion (phosphorylation?, ubiquitination?, etcetera) is required 
for degradation of both cyclins, and clam cyclin A competes 
for this reaction. In this connection Gtotzer et at. (1991) have 
recently reported that a protein A-sea urchin cyclin B hybrid 
molecule becomes multi-ubiquitinated at M phase in Xeno- 
pus egg extracts, suggesting the possibility that the ubiquitin 
conjugating system can be easily saturated. The rate of deac- 
tivation of cdc2 kinase was progressively decreased as cyclin 
concentration increased, providing evidence that degrada- 
tion of cyclin A is necessary to exit mitosis and may be the 
rate-limiting step for this cell cycle transition. Previous work 
with sea urchin cyclin B (Murray et al.,  1989) indicates its 
degradation  is  also  required,  suggesting  either  cyclin is 
sufficient to maintain metaphase arrest. 
When cyclin A was added to egg extracts, there was a con- 
sistent 10-min lag before kinase activation was evident. This 
lag was independent of cyclin concentration added, suggest- 
ing it was reflective of an event involved in altering the rate 
of cdc2 kinase activation. Recent studies that appeared after 
submission of this paper suggest that a similar lag seen with 
cyclin B addition to egg extracts reflects tyrosine and threo- 
nine phosphorylation and dephosphorylation events on cdc2 
kinase (Solomon et al.,  1991). Other studies show that the 
cdc25 gene product causes tyrosine and threonine dephos- 
phorylation of cdc2 in egg extracts and reduces the lag seen 
with saturating concentrations of cyclin B  (Kumagai and 
Dunphy, 1991). Apparently cyclin is only rate-limiting for 
cdc2 kinase activation if its level is below that needed to form 
adequate amounts of MPF, a situation probably not seen in 
vivo. Therefore, it seems possible that the cyclin-independent 
lag in activation seen here with cyclin A  may also reflect 
covalent modification of cdc2 and the action of cdc25 to in- 
duce tyrosine dephosphorylation of cdc2 kinase. However, 
Ferrell et at. (1991) found tyrosine phosphorylation of Xeno- 
pus cdc2 did not occur in mitoses 2-12, but a 10-min lag was 
still observed upon cyclin A addition to extracts that had al- 
ready exited from first mitosis in vitro (Fig. 5 C). 
Although our experiments and those reported by Solomon 
et at. (1991) have added cyclin at a single time point late in 
interphase, it may be useful in future work to examine other 
times of addition in the interest of finding differences in the 
properties of A- and B-type cyclin/cdc2 complexes. Recently 
Hunt and co-workers (Minshull et at.,  1990) found in time 
course studies of Murray extracts that cyclin A/cdc2  com- 
plexes became activated shortly after cyclin synthesis, where- 
as BI and B2 cyclin complexes accumulated in an inactive 
form and only became activated near the interphase/M phase 
boundary. This difference in the timing of  A and B cdc2 com- 
plexes may reflect a fundamental difference in the roles of the 
two cyclins, which so far have been largely indistinguishable 
by all available  functional measurements.  Further experi- 
ments with baculovirus-produced cyclin A  and B  should 
prove useful for studies comparing A- and B-type cyclins. 
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